Developing drugs from illegal compounds is challenging for companies as it does not look fiduciarily responsible, and they are only interested in substances if they can make billions of dollars. The outlaw of everything in the 1970s is also contributing to the difficulty of developing these drugs.
For-profit companies are interested in inventing and patenting new molecules of psychedelics, and this will unlock new places in our mind to explore. The heart of Greek and Western culture was the Eleusinian mysteries, which used a psychedelic potion called Kikiyan, similar to an LSD-like substance.
Psychedelic companies are facing challenges as they try to take a top down approach to their business, with many of them failing due to their business being not as easy as providing an addictive substance to people.
MDMA may have potential as an empathogen for increasing connection and awareness, but caution is advised for individuals under 25 years old or those who struggle with mental health disorders.
The next one to three years are a critical window to help people with trauma from what's happening in the country right now, and provide them with affordable and accessible treatment. This is a chance for people to be the sparks that light up the world in the most productive way possible, leading to lasting changes on a global level.
The use of psychedelics presents an incredible opportunity to understand how perception of reality can be altered in order to create intervention methods without causing addiction or lasting change. The medication is being used in small doses for adjunctive treatments in therapy with positive results.